Wienrich M

Title : Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man - Wienrich_2001_Life.Sci_68(22-23)_2593

Author(s) : Wienrich M , Meier D , Ensinger HA , Gaida W , Raschig A , Walland A , Hammer R

Ref : Life Sciences , 68 :2593 , 2001

Abstract :

PubMedSearch : Wienrich_2001_Life.Sci_68(22-23)_2593

PubMedID: 11392631

Title : Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease - Hock_2000_Ann.N.Y.Acad.Sci_920_285

Author(s) : Hock C , Maddalena A , Heuser I , Naber D , Oertel W , von der Kammer H , Wienrich M , Raschig A , Deng M , Growdon JH , Nitsch RM

Ref : Annals of the New York Academy of Sciences , 920 :285 , 2000

Abstract :

PubMedSearch : Hock_2000_Ann.N.Y.Acad.Sci_920_285

PubMedID: 11193166

Wienrich M

References (2)

1. Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man - Wienrich_2001_Life.Sci_68(22-23)_2593

2. Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease - Hock_2000_Ann.N.Y.Acad.Sci_920_285